Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMF + Steroids vs Steroids in Newly Diagnosed ITP
NCT06288932Phase 3Completed
- Sponsor
- National Institute of Blood and Marrow Transplant
- Start
- Aug 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mycophenolate mofetil in immune thrombocytopenia (ITP), sponsored by National Institute of Blood and Marrow Transplant. Started Aug 2023; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT06288932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06288932.